Numerous strategic acquisitions and expands in diverse portfolios have driven
STERIS Plc's (STE) continuous growth in its Healthcare segment. This sector saw a
9% growth and helped the company's revenue surge to
$1.3B in Q2. Despite the impressive improvement, there were periods the firm's stock
underperformed as compared to competitors. Multiple asset management firms have shown interest by buying tens of thousands of shares while others have sold significant shares of STE. The firm has also posted strong Q2 Earnings amid margin pressures. However, the company's international revenue trends have raised curiosity. The
earnings beat estimates in Q2 but had subsequent negative effects on margins, though the stock gained in aftermarket. Some divisions are divested, e.g., the dental sector, which pushes the company towards restructuring. Consequently, layoffs have been announced. Even as the company faces these challenges, its strong financial performance continues to retain its potential in the markets, showing
solid growth in Q2. Also, the board's chairman is set to retire in 2025, and the founder has sold his shares. \n
Steris Plc STE News Analytics from Wed, 24 Jun 2015 07:00:00 GMT to Fri, 22 Nov 2024 22:08:00 GMT -
Rating 5
- Innovation 6
- Information 7
- Rumor -5
